Hjem
Roland Jonssons bilde

Roland Jonsson

Professor emeritus, Tidl. Broegelmanns lærestol i immunologi
K2: Broegelmann FL
  • E-postRoland.Jonsson@uib.no
  • Telefon+47 55 97 46 49+47 911 48 189
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    Rom 
    5380
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2014). Genetic associations to germinal centre formation in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1253-1258.
  • Vis forfatter(e) (2014). CD11c+ dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients. Acta Dermato-Venereologica. 173-178.
  • Vis forfatter(e) (2014). A possible genetic association with chronic fatigue in primary Sjögren’s syndrome: a candidate gene study. Rheumatology International. 191-197.
  • Vis forfatter(e) (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 1284-1292.
  • Vis forfatter(e) (2013). Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scandinavian Journal of Immunology. 246-254.
  • Vis forfatter(e) (2013). Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study. Arthritis Care and Research. 816-821.
  • Vis forfatter(e) (2013). Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathogens. 10 sider.
  • Vis forfatter(e) (2013). No association of primary Sjögren's syndrome with Fcγ receptor gene variants. Genes and Immunity. 234-237.
  • Vis forfatter(e) (2013). NCR3/NKp30 contributes to pathogenesis in Primary Sjögren's Syndrome. Science Translational Medicine. 10 sider.
  • Vis forfatter(e) (2013). In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome. Arthritis Research & Therapy. 12 sider.
  • Vis forfatter(e) (2013). Glutaminyl cyclases as novel targets for the treatment of septic arthritis. Journal of Infectious Diseases. 768-777.
  • Vis forfatter(e) (2013). Characterization of monocyte-derived dendritic cells from immunosuppressed renal transplant recipients with and without squamous cell carcinomas. Scandinavian Journal of Immunology. 291-297.
  • Vis forfatter(e) (2013). Association of genes in the NF-kappa B pathway with antibody-positive Primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 447-454.
  • Vis forfatter(e) (2012). The risk of Non-Hodgkin Lymphoma in Primary Sjögren's Syndrome, a population-based study. Arthritis Care and Research.
  • Vis forfatter(e) (2011). Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Research & Therapy. 18 sider.
  • Vis forfatter(e) (2011). Potential association of muscarinic receptor 3 gene variants with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1327-1329.
  • Vis forfatter(e) (2011). Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1363-1368.
  • Vis forfatter(e) (2011). Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice. Autoimmunity. 415-426.
  • Vis forfatter(e) (2010). The fibroblast integrin alpha 11 beta 1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. Journal of Biological Chemistry. 10434-10445.
  • Vis forfatter(e) (2010). Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1235-1238.
  • Vis forfatter(e) (2009). The minor salivary gland proteome in Sjögren´s syndrome. Oral Diseases. 342-353.
  • Vis forfatter(e) (2009). Levels of dendritic cell populations and regulatory T cells vary significantly between two commonly used mouse strains. Scandinavian Journal of Immunology. 541-546.
  • Vis forfatter(e) (2009). Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome. Rheumatology. 1102-1106.
  • Vis forfatter(e) (2009). Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes and Immunity. 68-76.
  • Vis forfatter(e) (2008). Sjögrens syndrom. Norsk Epidemiologi. 67-72.
  • Vis forfatter(e) (2008). New Concepts in the Pathogenesis of Sjogren's Syndrome. Rheumatic Disease Clinics of North America. 833-+.
  • Vis forfatter(e) (2008). Exocrine function in primary Sjogren syndrome: natural course and prognostic factors. Annals of the Rheumatic Diseases. 949-954.
  • Vis forfatter(e) (2008). Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Research & Therapy. 14 sider.
  • Vis forfatter(e) (2007). Sjögren's syndrome - A plethora of clinical and immunological phenotypes with a complex genetic background. Annals of the New York Academy of Sciences. 433-447.
  • Vis forfatter(e) (2006). Polymyalgia rheumatica in primary Sjogren's syndrome. Rheumatology International. 401-403.
  • Vis forfatter(e) (2002). Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome. Laboratory Investigation. 203-210.
  • Vis forfatter(e) (2002). The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. European Journal of Immunology. 243-250.
  • Vis forfatter(e) (2002). The evolution and breakdown of the immune system: implications for development of autoimmune diseases. Scandinavian Journal of Immunology. 323-326.
  • Vis forfatter(e) (2002). Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scandinavian Journal of Immunology. 456-469.
  • Vis forfatter(e) (2002). Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. Journal of Infectious Diseases. 878-884.
  • Vis forfatter(e) (2002). Genetic aspects of Sjögren's syndrome. Arthritis Research. 353-359.
  • Vis forfatter(e) (2002). Current issues in Sjögren's syndrome. Oral Diseases. 130-140.
Vitenskapelig foredrag
  • Vis forfatter(e) (2019). Assessment of major salivary gland ultrasonography in Sjögren’s syndrome.
  • Vis forfatter(e) (2004). Sjögren's syndrome: Clinical presentation, biology and therapeutic approach.
  • Vis forfatter(e) (2004). Germinal Centres in Sjögren's syndrome.
  • Vis forfatter(e) (2004). Germinal Centers in Primary Sjögren�s Syndrome Indicate a Certain Clinical Immunological Phenotype.
  • Vis forfatter(e) (2003). The Association of B-cell Activating Factor (BAFF) and Ectopic Germinal Centre Formation in Sjögren’s Syndrome.
  • Vis forfatter(e) (2003). The Association of B-cell Activating Factor (BAFF) and Ectopic Germinal Center Formation in Sjögren’s Syndrome.
  • Vis forfatter(e) (2003). Sjögren's syndrome and experimental disease model system.
  • Vis forfatter(e) (2003). Genetic Control of Human and Experimental Sjögren's syndrome.
  • Vis forfatter(e) (2003). Apoptosis, loss of B cell tolerance and lymphoid neogenesis in Sjögren's syndrome.
  • Vis forfatter(e) (2003). Apoptosis and loss of B cell tolerance in Sjögren's syndrome.
  • Vis forfatter(e) (2002). What's new in Sjögren's syndrome: genetics?
  • Vis forfatter(e) (2002). The genetic control of human and experimental Sjögren's syndrome.
  • Vis forfatter(e) (2002). Subcellular redistribution and surface exposure of the Ro52, Ro60 and LA48 autoantigens during apoptosis in human ductual epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
  • Vis forfatter(e) (2002). Sjögren's syndrome: current issues in diagnosis, autoantibodies and pathogenesis.
  • Vis forfatter(e) (2002). Role of autoantibodies in Sjögren's syndrome.
  • Vis forfatter(e) (2002). Patogenese ved systemisk lupus erythematosus og Sjögren's syndrome.
  • Vis forfatter(e) (2002). Influenzaantigenspecific cells in human nasal mucosa.
  • Vis forfatter(e) (2002). Influenza-specific antibody producing cells in human nasal mucosa.
  • Vis forfatter(e) (2002). Influenza-specific antibody producing cells in human nasal mucosa.
  • Vis forfatter(e) (2002). Influenza specific antibodysecreting cells in nasal mucosa, prior to and after vaccination.
  • Vis forfatter(e) (2002). Influenza specific antibody secreting cells in nasal mucosa.
  • Vis forfatter(e) (2002). Immunology of the ocular surface and tearfilm: comparison of lacrimal and salivary glands.
  • Vis forfatter(e) (2002). Immunology of salivary glands diseases: the role of autoantibodies in Sjögren's syndrome.
  • Vis forfatter(e) (2002). Current understanding of Sjögren's syndrome.
  • Vis forfatter(e) (2001). The basal level of influenza specific antibody secreting cells in healthy subjects.
  • Vis forfatter(e) (2001). Influenza specific antibody secreting cells (I-ASC)in human nasal mucosa. Relation to tonsil, blood and parenteral vaccination.
  • Vis forfatter(e) (2001). Influensaantigenspecifika, antikroppsproducerande lymfocyter i human nasal slemhinne.
  • Vis forfatter(e) (2000). Monozygotic twins with primary Sjögren's syndrome.
  • Vis forfatter(e) (2000). HLA markers and clinical characteristics in caucasians with primary Sjögren's syndrome.
  • Vis forfatter(e) (2000). Fas-induced apoptosis is a rare event in Sjøgren's syndrome.
  • Vis forfatter(e) (2000). Antibodies against influenza virus secreted by tonsillar B cells following vaccination og young adults.
  • Vis forfatter(e) (1999). The 100-year anniversary of Henrik Sjögren.
  • Vis forfatter(e) (1999). Serological screening for hepatitis B, C and human herpes virus 6 in norwegian primary Sjögren's syndrome patients.
  • Vis forfatter(e) (1999). Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
  • Vis forfatter(e) (1999). Fine mapping of a locus in chromosome 2q involved in susceptibility for systemic lupus erythematosus.
  • Vis forfatter(e) (1999). Candidate gene analysis in patients with primary Sjögren´s syndrome: Screening for mutations in the Ro-52 gene.
  • Vis forfatter(e) (1999). Apoptosis and expression of apoptosis associated proteins in oral squamous cell carcinoma.
  • Vis forfatter(e) (1998). Transfer of human serum IgG to nonobese diabetic Ig<SUP>_mnull</SUP> mice reveals a role for autoanitbodies in the loss of secretory function of exocrine tissues in Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Transfer of human serum IgG to NOD. Ig<SUP>_mnull</SUP> mice reveals a role for autoantibodies in Sjögren´s syndrome.
  • Vis forfatter(e) (1998). The influence of different genes on the development of murine sialadenitis.
  • Vis forfatter(e) (1998). The influence of age on clinical features and laboratory parameters in primary Sjögren´s syndrome.
  • Vis forfatter(e) (1998). The influence of age on clinical features and laboratory findings in primary Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Supression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
  • Vis forfatter(e) (1998). Structural comparison of rheumatoid factors (RF) from patients with primary Sjögren´s syndrome, rheumatoid arthritis (RA), and healthy immunized donors (HID).
  • Vis forfatter(e) (1998). Sensitivity and reliability of diagnostic tests for primary Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Screening for mutations in the <I>La</I>-gene of patients with primary Sjögren´s syndrome by fluorescent labeling REF-SSCP technique.
  • Vis forfatter(e) (1998). Rheumatoid factor (RF) in primary Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Reliability and sensitivity of diagnostic tests in Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Molecular biology of tuberculosis.
  • Vis forfatter(e) (1998). Molecular biology of tubercolosis.
  • Vis forfatter(e) (1998). Influence of stress on immune cell recruitment in rat gingival tissues.
  • Vis forfatter(e) (1998). Increased number of IL-6 and IL-10 secreting cells in peripheral blood from patients with primary Sjögren´s syndrom.
  • Vis forfatter(e) (1998). Increased frequency of IL-6 and IL-10 secreting cells in peripheral blood from primary Sjögren´s syndrome patients.
  • Vis forfatter(e) (1998). Identification of susceptibility genes in Sjögren´s syndrome: The candidate gene approach.
  • Vis forfatter(e) (1998). Identification of susceptibility genes in Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Frequency of IFN-_g, IL-6 and IL-10 secreting cells in peripheral blood from primary Sjögren´s syndrome patients.
  • Vis forfatter(e) (1998). Distribution of HLA class II alleles in a Norwegian Population of Sjögren´s syndrome patients.
  • Vis forfatter(e) (1998). Detection of polymorphisms in the genes encoding Fas and Fas ligand in patients with primary Sjögren´s syndrome.
  • Vis forfatter(e) (1998). Critical antigens of <I>Fusobacterium nucleatum</I> which may play a role in the development of periodontitis.
  • Vis forfatter(e) (1998). Creation of primary murine models for Sjögren´s syndrome by replacement of NOD MHC.
  • Vis forfatter(e) (1998). Cooperative network on the genetics of systemic lupus erythematosus.
  • Vis forfatter(e) (1998). Compartmentalized immune responses in the spleens and lungs of chronically Mycobacterium tuberculosis infected mice.
  • Vis forfatter(e) (1998). Compartmentalized immune responses in the spleens and lungs of chronically Mycobacterium tuberculosis infected mice.
  • Vis forfatter(e) (1998). Compartmentalized immune responses in the spleens and lungs of chronically <I>mycobacterium tuberculosis</I> infected mice.
  • Vis forfatter(e) (1998). A novel mechanism of immune evasion by Mycobacterium tuberculosis.
  • Vis forfatter(e) (1998). A novel mechanism of immune evasion by <I>Mycobacterium tuberculosis</I>.
  • Vis forfatter(e) (1997). The prevalence of thyroid antibodies in primary Sj@øgren's syndrome (PSS).
  • Vis forfatter(e) (1997). Screening for mutations in the <i>fas</i> gene in patientes with primary Sj@øgren's syndrome.
  • Vis forfatter(e) (1997). Rheumatoid factor (RF) clones from patients with primary Sjøgren's syndrome (SS).
  • Vis forfatter(e) (1997). Rheumatoid factor (RF) clones from patients with primary Sjøgren's syndrome (SS).
  • Vis forfatter(e) (1997). Levels of spontaneous anti-Ro/SS-A secreting cells in peripheral blood and salivary glands of Sj@øgren's syndrome patients.
  • Vis forfatter(e) (1997). Genetics sharing og susceptibility to arthritis, sialadenitis, diabetes and encephalmoyelitis.
  • Vis forfatter(e) (1997). Expression of the "mucosal" lymphocyte integrin _a<sup>E</sup>_b<sub>7 </sub> and its ligand E-cadherin in salivary glands of Sj@øgren's syndrome patients.
  • Vis forfatter(e) (1997). Elispot assay for teh quantitation of B-cells producing antibodies against HIV-1 P24 in pharyngeal tonsils.
  • Vis forfatter(e) (1997). Different immunological abberations in patients with primary and secondary Sj@øgren's syndrome.
  • Vis forfatter(e) (1997). Collaborative network on the genetics of systemic lupus erythematosus and Sjøgren's syndrome: towards the determination of susceptibility loci through a genome-wide microsattelite scanning.
  • Vis forfatter(e) (1997). Collaborative network on the genetics of systemic lupus erythematosus and Sjøgren's syndrome: towards the determination of susceptibility loci through a genome-wide microsattelite scanning.
  • Vis forfatter(e) (1997). Characterisation of rheumatoid factor (RF) autoantibody clones in primary Sjøgren's syndrome.
  • Vis forfatter(e) (1997). Characterisation of Rheumatoid Factor (RF) autoantibody clones in primary Sjøgren's syndrome.
  • Vis forfatter(e) (1997). Calprotectin in oral fluids with special reference to adult periodontitis.
  • Vis forfatter(e) (1997). Apoptosis in oral lichen planus.
  • Vis forfatter(e) (1997). Apoptosis and expression of Fas and FasL in oral squamous cell carcinoma and normal oral mucosa.
  • Vis forfatter(e) (1997). Anti-Ro/SS-A and anti-La/SS-B antibodies in serum and saliva of patients with Sj@øgren's syndrome.
  • Vis forfatter(e) (1997). Anti-Ro and anti-La autoantibody producing cells in salivary glands from patients with Sj@øgren's syndrome.
  • Vis forfatter(e) (1997). Anti-Ro and anti-La autoantibody producing cells in salivary glands from patients with Sj@øgren's syndrome.
  • Vis forfatter(e) (1996). Mucosal antibodies to group B streptococci in the female genital tract. Abstract 67.
  • Vis forfatter(e) (1996). Local antibodies to group B streptococci in the cervix of pregnant women. Abstract R 11.
  • Vis forfatter(e) (1993). Sjögren's syndrome in Bergen during a two-years period. ENT symptoms in Sjögren's syndrome.
  • Vis forfatter(e) (1993). Sjögren's syndrome in Bergen during a two-years period. ENT symptoms in Sjögren's syndrome.
  • Vis forfatter(e) (1993). Antibodies against influenza virus secreted by tonsillar B cells following vaccination of young adults.
Vitenskapelig antologi/Konferanseserie
  • Vis forfatter(e) (2007). Immunologisk forskning i Bergen, Broegelmanns Forskningslaboratorim 1957-2007. Broegelmanns Legat.
Sammendrag/abstract
  • Vis forfatter(e) (2018). Ultrasonography of major salivary glands in juvenile Sjögren’s syndrome: an international multicentre study. Clinical and Experimental Rheumatology. S-248.
  • Vis forfatter(e) (2018). Salivary gland ultrasound in patients with Sjögren’s syndrome – A comparison between bed-side, video and still-image scoring. Clinical and Experimental Rheumatology. S-324.
  • Vis forfatter(e) (2018). Distinct and persistent cytokine profiles associated with histopathological features in primary Sjögren’s syndrome. Clinical and Experimental Rheumatology. S-295.
  • Vis forfatter(e) (2017). Primært Sjogrens syndrom karakteriseres av mikrobiell dysbiose (ubalanse) selv ved normal spyttsekresjon. Den norske tannlegeforenings tidende. 262-263.
  • Vis forfatter(e) (2013). Type 1 Regulatory T cells and Regulatory B Cells Induced by Dexamethasone and 1,25-Dihydroxyvitamin D3 Treated Monocyte-Derived Dendritic Cells. Scandinavian Journal of Immunology. 299-300.
  • Vis forfatter(e) (2013). The NKp30/B7H6 Axis Contributes To Pathogenesis In Primary Sjogren's Syndrome. Arthritis and Rheumatism. S1185-S1185.
  • Vis forfatter(e) (2013). The Importance Of Germinal Center-Like Structures In Primary Sjogren's Syndrome Salivary Glands Beyond Lymphoma Risk. Arthritis and Rheumatism. S1234-S1234.
  • Vis forfatter(e) (2013). Modulation of experimental Sjögren's Syndrome and diabetes via mucosal vaccination with fusion proteins derived from cholera-toxin and heat shock protein 60 kDa. Scandinavian Journal of Immunology. 321-321.
  • Vis forfatter(e) (2013). Is Ultrasonography Of Salivary Gland a Validate Tool In Sjogren Syndrome? Study 1: Interobserver Reliability Between International Group Of Experts. Arthritis and Rheumatism. S223-S223.
  • Vis forfatter(e) (2013). Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding. Arthritis and Rheumatism. S1184-S1185.
  • Vis forfatter(e) (2013). Carbamylation of immunoglobulin abrogates the classical pathway of complement activation. Immunology. 76-76.
  • Vis forfatter(e) (2012). Ultrasonography of Major Salivary Glands in Primary Sjogren's syndrome. Arthritis and Rheumatism. S925-S925.
  • Vis forfatter(e) (2012). No association of primary Sjögren's Syndrome with Fc gamma? Receptor gene variants. Scandinavian Journal of Immunology. 198-198.
  • Vis forfatter(e) (2012). Modulation of experimental Sjögren's syndrome and diabetes via mucosal vaccination with fusion proteins derived from cholera-toxin and heat shock protein 60 kDa. Immunology. 766-766.
  • Vis forfatter(e) (2012). Hyperreactive B cells upon endosomal TLR triggering underlying primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 199-200.
  • Vis forfatter(e) (2012). Genetic associations to germinal centre formation in primary Sjögren's syndrome. Immunology. 580-580.
  • Vis forfatter(e) (2012). Genetic associations to germinal centre formation in primary Sjögren's Syndrome. Arthritis and Rheumatism. S227-S227.
  • Vis forfatter(e) (2012). Genetic associations to germinal centre formation in primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 203-203.
  • Vis forfatter(e) (2012). Genetic Variation in the NCR3 Locus Is Associated with Anti-SSA/SSB Positive Primary Sjogren's Syndrome in Scandinavian Samples. Arthritis and Rheumatism. S228-S228.
  • Vis forfatter(e) (2012). Expression of Toll-like receptors 7 and 9 in B cell populations of patients with Sjogren's syndrome. Immunology. 331-331.
  • Vis forfatter(e) (2012). Comparison of different protocols for the generation of monocytes-derived tolerogenic dendritic cells for immunotherapy. Immunology. 679-679.
  • Vis forfatter(e) (2012). A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome. Arthritis and Rheumatism. S1133-S1133.
  • Vis forfatter(e) (2011). Vaccination of patients with primary Sjögren's syndrome reveals hyperreactive B cell compartment with a skewed maturation pattern. Annals of the Rheumatic Diseases. A67-A67.
  • Vis forfatter(e) (2011). Vaccination of Patients with Primary Sjogren's Syndrome Reveals Hyperreactive B Cell Compartment. Scandinavian Journal of Immunology. 369-369.
  • Vis forfatter(e) (2011). Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjogren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome. Arthritis and Rheumatism. S251-S251.
  • Vis forfatter(e) (2011). Maturation of Dendritic Cells with the Bacterial Compound OK432 Induces High Secretion of IL-12p70 in a TLR3 Dependent Manner. Scandinavian Journal of Immunology. 387-388.
  • Vis forfatter(e) (2011). Large-Scale, High-Density Genotyping Performed by the Sjogren's Genetics Network Using the ImmunoChip Identifies PRKRA as a Novel Sjogren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC. Arthritis and Rheumatism. S303-S304.
  • Vis forfatter(e) (2011). Generation of Tolerogenic Monocyte-Derived Dendritic Cells. Scandinavian Journal of Immunology. 378-379.
  • Vis forfatter(e) (2011). Can Levels of Blood Plasmacytoid Dendritic Cells be used as a Prognostic Factor for Development of Squamous Cell Carcinomas in Organ Transplant Recipients? Scandinavian Journal of Immunology. 394-394.
  • Vis forfatter(e) (2011). A High-Density Genome-Wide Association Study by the Sjogren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjogren's Syndrome and Confirms Association with MHC, IRF5, and BLK. Arthritis and Rheumatism. S184-S184.
  • Vis forfatter(e) (2010). Prednisolon Reduce Cytokine but Increase Autoantibody Levels in Patients with Primary Sjogren's Syndrome. Scandinavian Journal of Immunology. 491-491.
  • Vis forfatter(e) (2010). Patients with Primary Sjogren's Syndrome have Significantly Reduced Amounts of Plasmacytoid and Type 2 Myeloid Dendritic Cells in Peripheral Blood. Scandinavian Journal of Immunology. 479-479.
  • Vis forfatter(e) (2010). Maturation of Monocyte Derived Dendritic Cells With OK432 Leads to Altered Expression of Surface Markers. Scandinavian Journal of Immunology. 504-504.
  • Vis forfatter(e) (2010). Gene Variants in Fam167A-Blk and Tnfsf4 are associated with Primary Sjogren's Syndrome. Scandinavian Journal of Rheumatology. 32-32.
  • Vis forfatter(e) (2010). Fc gamma receptor IIA, IIIA and IIIB single nucleotide polymorphisms and Fc gamma receptor IIIB copy number variation: No association with primary Sjögren's syndrome. Scandinavian Journal of Rheumatology. 36-36.
  • Vis forfatter(e) (2010). Association between Lymphotoxin Alpha Genetic Variants and Primary Sjögren`s Syndrome in Scandinavian Samples. Arthritis and Rheumatism. 788-789.
  • Vis forfatter(e) (2008). Use of bladder capacity and uroflowmetry to elucidate lower urinary tract symptoms (LUTS) in primary Sjögren’s Syndrome (PSS). Annals of the Rheumatic Diseases. 617-617.
  • Vis forfatter(e) (2008). Maturation of monocyte derived dendritic cells with OK432 leads to altered expression of surface markers. Scandinavian Journal of Immunology. 217-217.
  • Vis forfatter(e) (2008). Inhibition of experimental Sjögren's syndrome through immunization with heat-shock protein 60kDa and its peptide aa437-460. Arthritis and Rheumatism. S795-S795.
  • Vis forfatter(e) (2008). Histopathology in Seropositive Focus Score Negative Primary Sjögren’s Syndrome. Annals of the Rheumatic Diseases. 470-470.
  • Vis forfatter(e) (2008). Heterogeneity of plasma cell subsets found in the bone marrow of autoimmune NOD.B10.H2b mice. Scandinavian Journal of Immunology. 206-206.
  • Vis forfatter(e) (2008). Autoantigens Ro52 and Ro60 but not La48 are associated to membrane structures in HeLa cells. Scandinavian Journal of Immunology. 202-202.
  • Vis forfatter(e) (2008). Association of Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) with BLK. Clinical Immunology. S41-S41.
  • Vis forfatter(e) (2008). Association of BLK with Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) initially identified by whole genome DNA pooling. Arthritis and Rheumatism. S791-S791.
  • Vis forfatter(e) (2008). Age-related distribution of cDC and pDC in salivary glands of NOD mice. Scandinavian Journal of Immunology. 206-207.
  • Vis forfatter(e) (2008). Additive effects of the major risk Alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Arthritis and Rheumatism. S430-S430.
  • Vis forfatter(e) (2007). Regulation of alpha11beta1 integrin levels in vitro; Identification of mechanical strain as a positive regulator of alpha11 integrin expression. Inflammation Research. S391.
  • Vis forfatter(e) (2007). Identification of cell surface autoantigens in Sjögren's syndrome. Inflammation Research. S457-S457.
  • Vis forfatter(e) (2007). Current understanding of Sjögren's syndrome. European Journal of Clinical Investigation. 32-32.
  • Vis forfatter(e) (2006). News and views about Sjogren's syndrome. Scandinavian Journal of Rheumatology. 28-29.
  • Vis forfatter(e) (2006). Germinal centers in primary Sjogren's syndrome indicate a certain clinical immunological phenotype. Scandinavian Journal of Rheumatology. 21-22.
  • Vis forfatter(e) (2006). Exocrine function in Sjogren's syndrome: Natural course and prognostic factors. Annals of the Rheumatic Diseases.
  • Vis forfatter(e) (2004). Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjogren&apos;s syndrome with a special 2 emphasis on BAFF. Arthritis and Rheumatism. S578-S578.
  • Vis forfatter(e) (2004). Gene expression profiling of minor salivary glands in primary Sjögren's syndrome clearly groups patients and healthy control indiviluals. Arthritis and Rheumatism. S577-S577.
  • Vis forfatter(e) (2004). Apoptosis, loss of B-cell tolerance and lymphoid neogenesis in Sjogren&apos;s syndrome. Arthritis Research & Therapy. S50-S50.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2022). Disease mechanisms in Sjögren’s syndrome: What do we know? Scandinavian Journal of Immunology.
  • Vis forfatter(e) (2019). Primary Sjögren's syndrome and the eye. Survey of ophthalmology. 119-132.
  • Vis forfatter(e) (2016). Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. Clinical and Experimental Rheumatology. 133-142.
  • Vis forfatter(e) (2014). Comparison of the American-European Consensus Group Sjögren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Annals of the Rheumatic Diseases. 31-38.
  • Vis forfatter(e) (2012). Predictors for the development of non-Hodgkin lymphoma in primary Sjögren’s syndrome. La Médicale. 511.
  • Vis forfatter(e) (2012). Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmunity Reviews. 276-280.
  • Vis forfatter(e) (2011). The complexity of Sjögren's syndrome: Novel aspects on pathogenesis. Immunology Letters. 1-9.
  • Vis forfatter(e) (2011). Sjögren's syndrome: studying the disease in mice. Arthritis Research & Therapy. 16 sider.
  • Vis forfatter(e) (2010). Sjögren's Syndrome. Encyclopedia of Life Sciences.
  • Vis forfatter(e) (2009). Aspects of B-cell non-Hodgkin's lymphoma development: A transition from immune-reactivity to malignancy. Scandinavian Journal of Immunology. 387-400.
  • Vis forfatter(e) (2008). The complex role of vitamin D in autoimmune diseases. Scandinavian Journal of Immunology. 261-269.
  • Vis forfatter(e) (2008). Anti-CD20 treatment in Primary Sjogren's Syndrome. Scandinavian Journal of Immunology. 554-564.
  • Vis forfatter(e) (2007). Role of B cells in Sjögren's syndrome - from benign lymphoproliferation to overt malignancy. Frontiers in Bioscience. 2159-2170.
  • Vis forfatter(e) (2007). Animal models of Sjögren's syndrome. Clinical reviews in allergy and immunology. 215-224.
  • Vis forfatter(e) (2006). Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: A potential breakthrough diagnostic and individualized therapy-design tool. Scandinavian Journal of Immunology. 236-242.
  • Vis forfatter(e) (2005). Sjögren's syndrome. European Journal of Oral Sciences. 101-113.
  • Vis forfatter(e) (2005). Gene therapeutics in Sjögren's syndrome. Expert Opinion on Biological Therapy. 763-772.

Se fullstendig oversikt over publikasjoner i CRIStin.